Deventer Ziekenhuis Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01362959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Deventer Ziekenhuis

Active Ingredients

Drugs in Phase 4 Trials (2)

Atosiban (tractocile) (1 trial)

nicotine (nicorette) (1 trial)

Drugs in Phase 3 Trials (2)

clonidine (catapres) (2 trials)

sodium chloride (1 trial)

Drugs in Other Trials (3)

bintrafusp alfa (1 trial)

carboplatin (paraplatin) (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Critical Illness (Phase 3)

Delirium (Phase 4)

Psychomotor Agitation (Phase 4)

Substance Withdrawal Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7